Sign Out
Each extended-release tablet contains upadacitinib hemihydrate, equivalent to 15 mg of upadacitinib.
Excipients/Inactive Ingredients: Tablet contents: Microcrystalline cellulose, Hypromellose, Mannitol, Tartaric acid, Colloidal anhydrous silica, Magnesium stearate.
Film coating: Poly(vinyl alcohol), Macrogol, Talc, Titanium dioxide (E171), Iron oxide black (E172) (15 mg strength only), Iron oxide red (E172).
